Find Peramivir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

3 RELATED EXCIPIENT COMPANIES

3EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 330600-85-6, Bcx-1812, 229614-55-5, Rapiacta, Rwj-270201, Rapivab
Molecular Formula
C15H28N4O4
Molecular Weight
328.41  g/mol
InChI Key
XRQDFNLINLXZLB-CKIKVBCHSA-N
FDA UNII
9ZS94HQO3B

Peramivir
Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.
1 2D Structure

Peramivir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid
2.1.2 InChI
InChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1
2.1.3 InChI Key
XRQDFNLINLXZLB-CKIKVBCHSA-N
2.1.4 Canonical SMILES
CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C
2.1.5 Isomeric SMILES
CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C
2.2 Other Identifiers
2.2.1 UNII
9ZS94HQO3B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (1s,2s,3r,4r)-3-((1s)-1-acetamido-2-ethylbutyl)-4-((amino(imino)methyl)amino)-2-hydroxycyclopentanecarboxylic Acid Trihydrate

2. 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic Acid

3. Bcx 1812

4. Bcx-1812

5. Bcx1812

6. Peramivir Trihydrate

7. Rapivab

8. Rwj 270201

9. Rwj-270201

10. Rwj270201

2.3.2 Depositor-Supplied Synonyms

1. 330600-85-6

2. Bcx-1812

3. 229614-55-5

4. Rapiacta

5. Rwj-270201

6. Rapivab

7. Peramivir Anhydrous

8. Chebi:85202

9. Bcx1812

10. Bcx 1812

11. Peramivir, (+/-)-

12. Rwj270201

13. (1s,2s,3s,4r)-3-[(1s)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic Acid

14. 229614-56-6

15. Rwj 270201

16. 9zs94hqo3b

17. Idl9q29886

18. (1s,2s,3r,4r)-3-((s)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic Acid

19. 330600-85-6 (free)

20. (1s,2s,3r,4r)-4-carbamimidamido-3-[(1s)-1-acetamido-2-ethylbutyl]-2-hydroxycyclopentane-1-carboxylic Acid

21. 3-(1-acetylamino-2-ethyl-butyl)-4-guanidino-2-hydroxy-cyclopentanecarboxylic Acid

22. 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic Acid

23. Bcz

24. Cyclopentanecarboxylic Acid, 3-[(1s)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1s,2s,3r,4r)-

25. (+/-)-peramivir

26. Peramivir [usan:inn]

27. Unii-9zs94hqo3b

28. Peramiflu

29. Unii-idl9q29886

30. S-021812

31. Cyclopentanecarboxylic Acid, 3-((1s)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1s,2s,3r,4r)-

32. Peramivir [inn]

33. Peramivir [mi]

34. Schembl744373

35. Bdbm5024

36. Chembl139367

37. Schembl12795462

38. Dtxsid10904727

39. Bcpp000117

40. (1s,2r,3r,4r)-3-(1-acetamido-2-ethyl-butyl)-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic Acid

41. Zinc3981610

42. Bdbm50181441

43. Hy-17015a

44. Mfcd09837902

45. Akos016007760

46. Akos037652424

47. Peramivir (+/-)-form [mi]

48. Cs-0638

49. Db06614

50. Dt-0029

51. Ncgc00346433-06

52. Ncgc00346433-07

53. (1s,2s,3r,4r)-3-((1s)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino)-2-hydroxycyclopentane

54. (1s,2s,3r,4r)-3-((s)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic Acid

55. Ac-22715

56. Cyclopentanecarboxylic Acid, 3-((1r)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1r,2r,3s,4s)-rel-

57. P2892

58. W19713

59. Ab01566838_01

60. 600p856

61. A896277

62. Q412734

63. (-)-(1s,2s,3r,4r)-3-[(1s)-1-(acetylamino)-2-ethylbutyl]-4-{[amino(imino)methyl]amino}-2-hydroxycyclopentanecarboxylic Acid

64. (1s,2s,3r,4r)-3-((1s)-1-acetylamino-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxycyclopentanecarboxylic Acid

65. (1s,2s,3r,4r)-3-[(1s)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic Acid Trihydrate

66. (1s,2s,3r,4r)-3-[(1s)-1-(acetylamino)-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentanecarboxylic Acid

67. (1s,2s,3r,4r)-3-[(1s)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic Acid

68. (1s,2s,3r,4r)-3-[(1s)-1-acetamido-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentane-1-carboxylic Acid

69. (1s,2s,3s,4r)-4-[(diaminomethylidene)amino]-3-[(1s)-1-acetamido-2-ethylbutyl]-2-hydroxycyclopentane-1-carboxylic Acid

70. Cyclopentanecarboxylic Acid, 3-((1s)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1r,2r,3s,4s)-rel-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 328.41 g/mol
Molecular Formula C15H28N4O4
XLogP30
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass328.21105539 g/mol
Monoisotopic Mass328.21105539 g/mol
Topological Polar Surface Area151 Ų
Heavy Atom Count23
Formal Charge0
Complexity460
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.


FDA Label


Alpivab is indicated for the treatment of uncomplicated influenza in adults and children from the age of 2 years.


Treatment of influenza


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


5.2 ATC Code

J05AH03


J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AH - Neuraminidase inhibitors

J05AH03 - Peramivir


5.3 Mechanism of Action

Peramivir is an inhibitor of influenza neuraminidase, preventing new virus particles from leaving infected cells.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633631400,"product":"PACKED IN 05 LTR HDPE DRUM - PERAMIVIR R","address":"25, 12TH CROSS STREET, SHASTRI NAGAR,","city":"CHENNAI\/TAMILNADU","supplier":"NURAY CHEMICALS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"THE PURCHASE MANAGER","customerCountry":"TAIWAN","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"10000","totalValueFC":"574","currency":"USD","unitRateINR":716666.66666666674,"date":"08-Oct-2021","totalValueINR":"43000","totalValueInUsd":"574","indian_port":"MADRAS AIR","hs_no":"29349990","bill_no":"5169436","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"MADRAS AIR","supplierAddress":"25, 12TH CROSS STREET, SHASTRI NAGAR,, CHENNAI\/TAMILNADU","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637519400,"product":"PERAMIVIR","address":"25, 12TH CROSS STREET, SHASTRI NAGAR,","city":"CHENNAI\/TAMILNADU","supplier":"NURAY CHEMICALS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"THE PURCHASE MANAGER-","customerCountry":"TAIWAN","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"10000","totalValueFC":"966.8","currency":"USD","unitRateINR":720000,"date":"22-Nov-2021","totalValueINR":"72000","totalValueInUsd":"966.8","indian_port":"MADRAS AIR","hs_no":"29349990","bill_no":"6170090","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"MADRAS AIR","supplierAddress":"25, 12TH CROSS STREET, SHASTRI NAGAR,, CHENNAI\/TAMILNADU","customerAddress":""}]
08-Oct-2021
22-Nov-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Peramivir Manufacturers

A Peramivir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Peramivir, including repackagers and relabelers. The FDA regulates Peramivir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Peramivir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Peramivir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Peramivir Suppliers

A Peramivir supplier is an individual or a company that provides Peramivir active pharmaceutical ingredient (API) or Peramivir finished formulations upon request. The Peramivir suppliers may include Peramivir API manufacturers, exporters, distributors and traders.

click here to find a list of Peramivir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Peramivir USDMF

A Peramivir DMF (Drug Master File) is a document detailing the whole manufacturing process of Peramivir active pharmaceutical ingredient (API) in detail. Different forms of Peramivir DMFs exist exist since differing nations have different regulations, such as Peramivir USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Peramivir DMF submitted to regulatory agencies in the US is known as a USDMF. Peramivir USDMF includes data on Peramivir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Peramivir USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Peramivir suppliers with USDMF on PharmaCompass.

Peramivir KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Peramivir Drug Master File in Korea (Peramivir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Peramivir. The MFDS reviews the Peramivir KDMF as part of the drug registration process and uses the information provided in the Peramivir KDMF to evaluate the safety and efficacy of the drug.

After submitting a Peramivir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Peramivir API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Peramivir suppliers with KDMF on PharmaCompass.

Peramivir WC

A Peramivir written confirmation (Peramivir WC) is an official document issued by a regulatory agency to a Peramivir manufacturer, verifying that the manufacturing facility of a Peramivir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Peramivir APIs or Peramivir finished pharmaceutical products to another nation, regulatory agencies frequently require a Peramivir WC (written confirmation) as part of the regulatory process.

click here to find a list of Peramivir suppliers with Written Confirmation (WC) on PharmaCompass.

Peramivir NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Peramivir as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Peramivir API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Peramivir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Peramivir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Peramivir NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Peramivir suppliers with NDC on PharmaCompass.

Peramivir GMP

Peramivir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Peramivir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Peramivir GMP manufacturer or Peramivir GMP API supplier for your needs.

Peramivir CoA

A Peramivir CoA (Certificate of Analysis) is a formal document that attests to Peramivir's compliance with Peramivir specifications and serves as a tool for batch-level quality control.

Peramivir CoA mostly includes findings from lab analyses of a specific batch. For each Peramivir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Peramivir may be tested according to a variety of international standards, such as European Pharmacopoeia (Peramivir EP), Peramivir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Peramivir USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty